[Aurornis]

Everyone likes to bash the US healthcare system, but at the same time it’s remarkable how much subsidized GLP-1 access Americans are getting compared to much of the world. The paradox of discussing healthcare online.

[refurb]

It’s not just GLP-1s.

Look at CAR-T therapies (your cells are reprogrammed to fight your cancer). Insured patients got access in the US long before, and to a broader degree, than national healthcare systems.

Today, CAR-T utilization in cancers like lymphoma are double those of Europe in many cases. Interestingly the UK is one of the highest in Europe (despite the controversy over cancer drug spending).

While true that the US has uninsured and not all insurance is equal, suffice to say you stand a better chance to get access to new technologies in the US than most countries.

[jandrese]

Not to put too fine a point on it but Americans are one of the primary markets for these drugs because the obesity problem is especially acute.

[petesergeant]

> it’s remarkable how much subsidized GLP-1 access Americans are getting

Mounjaro is between 25-50% of the US price in other countries

[Aurornis]

I was referring to insurance coverage. Most people aren’t paying that inflated price.

Whenever you see a very large number for a medication or service in the United States, the patient doesn’t actually pay that number.

Companies generally have separate coverage programs for people paying out of pocket that drastically reduces the patient pay amount.

Those giant numbers attached to medications are virtually never paid by the patient.

[petesergeant]

It’s hard to find hard data on this but this[0] seems to think 20-30% of plans will cover for obesity.

The Lily and Novo Nordisk coupons seem to have quite short availability windows, according to several years of reading the various related subreddits.

The cost difference here is real.

0: https://www.goodrx.com/insurance/health-insurance/weight-los...

[pjc50]

Subsidized by whom?